Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease

British Journal of Clinical Pharmacology

Volumn 71, Issue 1, 2011, Pages 132-136

  Giraldi, Francesca Pecori ^a,b   Ambrogio, Alberto G ^a   Fatti, Letizia M ^b   Rubini, Valentina ^a   Cozzi, Giovanna ^a   Scacchi, Massimo ^a,b   Federici, Augusto B ^a   Cavagnini, Francesco ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Cushing's disease; Desmopressin; Plasminogen activator inhibitor 1; Tissue plasminogen activator; Von Willebrand factor

Indexed keywords

DESMOPRESSIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DIAGNOSTIC TEST; FEMALE; FIBRINOLYSIS; HUMAN; MALE; OBESITY; PRIORITY JOURNAL;

BODY WEIGHT; CASE-CONTROL STUDIES; DEAMINO ARGININE VASOPRESSIN; FIBRINOLYSIS; HUMANS; PITUITARY ACTH HYPERSECRETION; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 78650022228     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03812.x     Document Type: Article

References (13)

1. Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM. Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 2000; 23: 145-50.
2. Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MB, Fliers E, Gerdes VEA, Büller HR, Brandjes DPM. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 2009; 94: 2743-50.
3. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003; 1: 682-9.
4. Invitti C, Pecori Giraldi F, De Martin M, Cavagnini F, the Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. J Clin Endocrinol Metab 1999; 84: 440-8.
5. Moro M, Putignano P, Losa M, Invitti C, Maraschini C, Cavagnini F. The desmopressin test in the differential diagnosis between Cushing's disease and pseudoCushing states. J Clin Endocrinol Metab 2000; 85: 3569-74.
6. Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 2002; 8: 607-21.
7. Federici AB, Canciani MT, Forza I, Mannucci PM, Marchese P, Ware J, Ruggeri ZM. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibα for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004; 89: 77-85.
8. Campbell MJ, Gardner MJ. Calculating confidence intervals for some non-parametric analyses. Br Med J 1988; 296: 1454-6.
9. Malerbi DA, Bilharinho de Mendonça B, Liberman B, Toledo SPA, Corradini MCM, Cunha-Neto MB, Villares Fragoso MCB, Wajchenberg BL. The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol 1993; 38: 463-72.
10. Machado MC, De Sa SV, Domenice S, Villares Fragoso MCB, Puglia Jr P, Albergaria Pereira MA, Bilharinho de Mendonça B, Salgado LR. The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing's syndrome. Clin Endocrinol 2007; 66: 136-42.
11. Losa M, Bianchi R, Barzaghi R, Giovanelli M, Mortini P. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease. J Clin Endocrinol Metab 2009; 94: 3322-8.
12. La Brocca A, Terzolo M, Pia A, Paccotti P, De Giuli P, Angeli A. Recurrent thromboembolism as a hallmark of Cushing's syndrome. J Endocrinol Invest 1997; 21: 211-4.
13. Crescenzi G, Landoni G, Biondi-Zoccai G Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A. Desmopressin reduces transfusion needs after surgery. Anesthesiology 2008; 109: 1063-76.